Recruiting

Supraglottic Airway

Sponsor:

Ann & Robert H Lurie Children's Hospital of Chicago

Code:

NCT02202174

Conditions

Supraglottic Airway Use in Children

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Accepted

Interventions

Supraglottic Airway Device

Study Details

Brief summary:

This purpose of this study is to determine the effectiveness, risk factors, and complications associated with use of supraglottic airway devices for primary airway maintenance during routine anesthesia in children.

Conditions

Supraglottic Airway Use in Children

Study ID

NCT02202174

Start date

Jun, 2014

Status verified date

Jul, 2015

Completion date

Oct, 2015

Anticipated

Primary completion date

Oct, 2015

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Children undergoing anesthesia with use of a supraglottic airway device as a primary means of oxygenation \& ventilation

Exclusion Criteria:

  • N/A

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Arms

Supraglottic Airway Device

Patients will receive a supraglottic airway device as a primary means of ventilation. The following devices may be used: LMA Unique, LMA ProSeal, LMA Supreme, LMA Flexible, Ambu Aura-I, Ambu Aura Once, Air-Q, I-Gel, or other supraglottic airway device. Choice of the device will be clinician dependent and based on the patients body weight per manufacturer guidelines

Interventions

Supraglottic Airway Device

Primary outcome measure

  • Supraglottic Airway Device Failure [ Time Frame: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours ]

Central Contacts and Locations

Central contacts

Narasimhan Jagannathan, MD

3122275170njagannathan@luriechildrens.org

Locations

Ann & Robert H. Lurie Children's Hospital of Chicago

Recruiting

Chicago, Illinois, United States, 60611

Contacts

Narasimhan Jagannathan, MD

simjag2000@yahoo.com

Principal Investigator:

Narasimhan Jagannathan, MD

More Information

Sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Last update posted

Jul 29, 2015

Last verified

Jul, 2015

Keywords

  • supraglottic airway
  • children
  • safety
  • efficacy

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Ann & Robert H Lurie Children's Hospital of Chicago on 2015-07-29.